US Stock MarketDetailed Quotes

NRXP NRX Pharmaceuticals

Watchlist

4.1800
-0.1200-2.79%

Close Apr 17 16:00 ET

3.4400
-0.7400-17.70%

Post 19:42 ET

40.00MMarket Cap-1045P/E (TTM)

NRX Pharmaceuticals Stock Forum

Jaguar8

5 hours ago

$NRX Pharmaceuticals(NRXP.US)$
NEWS
NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
RADNOR, Pa., April 17, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical company, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares of common stock are to be sold by the Company. The offering is subject to ...

Trytosaveabit

13 hours ago

Update

$NRX Pharmaceuticals(NRXP.US)$ NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile Infections

Yuanhunglo

Apr 12 07:50

$NRX Pharmaceuticals (NRXP.US)$ Hopefully, that's just a preview!

Sean Parker

Apr 12 05:24

good run today

$NRX Pharmaceuticals(NRXP.US)$

Sean Parker

Apr 11 16:13

good

$NRX Pharmaceuticals(NRXP.US)$ today announced that the Company has achieved data-lock in its Phase 2b/3 Suicidal Treatment Resistant Bipolar Depression Study with NRX-101. With data-lock, as forecast in last week's earnings call, the complete data set passed on for statistical analysis; top-line data release expected in April 2024.
With positive data from this study and FDA comment, NRx becomes eligible to receive the balance of its first milestone (an additional $4 million) from partners...

Trytosaveabit

Apr 8 07:38

Watching

$NRX Pharmaceuticals(NRXP.US)$ NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
7 MINUTES AGO, 8:30 AM EDT
VIA PR NEWSWIRE
• Data transferred for independent statistical analysis
• Top-line data expected in April 2024

Trytosaveabit

Apr 1 07:32

Lots of great info here!

$NRX Pharmaceuticals(NRXP.US)$ PR Newswire
RADNOR, Pa., April 1, 2024
Four potential near-term milestones, including data from two clinical trials, an NDA filing and an upcoming share dividend
-- 50% reduction in corporate overhead and 25% reduction in overall net loss in 2023, compared to 2024 with $0.20 per share improvement in negative earnings. Additions to working capital of $8 million in Q1 2024.
-- Company forecasts first commercial revenue in 2024 from sales of ke...

Om Sai Ram

Mar 12 15:27

$NRX Pharmaceuticals(NRXP.US)$
Before RS, either they should be a huge news to shoot up the price or else have to wait till RS completion

xxxjaystation

Mar 12 12:38

$NRX Pharmaceuticals(NRXP.US)$ Nevermind I'll come back post R/S

Trytosaveabit

Mar 12 06:52

Plan to defeat naked short selling!

$NRX Pharmaceuticals(NRXP.US)$ RADNOR, Pa., March 12, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company") today initiated actions to combat short sellers in the Company's stock.
The Company announced a proposal to simultaneously change the CUSIP under which the Company's shares are traded, together with changing the name of the Company to NRx Therapeutics, Inc. The Company plans to accompany these actions with a ...

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall